Greninger, D A <br/><br/>
The use of factor VIII/von Willebrand factor concentrate for immune tolerance induction in haemophilia A patients with high-titre inhibitors: association of clinical outcome with inhibitor epitope profile.  [electronic resource] 

 -  Haemophilia : the official journal of the World Federation of Hemophilia  Mar 2008 
 - 295-302 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1365-2516 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2516.2007.01620.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Autoantibodies--blood<br/>B-Lymphocytes--immunology<br/>Child<br/>Child, Preschool<br/>Drug Combinations<br/>Epitope Mapping<br/>Epitopes--analysis<br/>Factor VIII--immunology<br/>Genotype<br/>Hemophilia A--drug therapy<br/>Hemostatics--therapeutic use<br/>Humans<br/>Immune Tolerance<br/>Infant<br/>Infant, Newborn<br/>Retrospective Studies<br/>Treatment Outcome<br/>von Willebrand Factor--therapeutic use